重組小鼠 LRIG1 / LIG-1 蛋白|Mouse LRIG1 / LIG-1 Protein|技術資料|產品詳情

LRIG1 / LIG-1蛋白產品信息
產品名稱：重組小鼠 LRIG1 / LIG-1 蛋白|Mouse LRIG1 / LIG-1 Protein|技術資料|產品詳情
別名: D6Bwg0781e, Img, LIG-1
表達方式: A DNA sequence encoding the extracellular domain of mouse LRIG1 ( NP_032403.2 ) ( Met 1 - Thr 794 ) was expressed, with a polyhistidine tag at the C-terminus
種屬: Mouse
表達宿主: Human Cells

LRIG1 / LIG-1蛋白質控指標
純度: > 95 % as determined by SDS-PAGE SDS-PAGE:
內**: < 1.0 EU per μg of the protein as determined by the LAL method
穩定性: Samples are stable for up to twelve months from date of receipt at -70℃
預測N端: Ala 35
分子量: The recombinant mouse LRIG1 consists of 771 amino acids and has a predicted molecular mass of 85 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rm LRIG1 is approximately 90-100 kDa due to glycosylation
緩沖液: Lyophilized from sterile PBS , pH 7.4
Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Please contact us for any concerns or special requirements.
LRIG1 / LIG-1蛋白使用指南
儲存方法: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.
LRIG1 / LIG-1蛋白背景綜述
Mouse Leucine-rich repeats and immunoglobulin-like domains protein 1, also known as LIG-1 and LRIG1, is a single-pass type I membrane protein which is widely expressed. LRIG1 / LIG-1 contains 3 Ig-like C2-type (immunoglobulin-like) domains, 15 LRR (leucine-rich) repeats, 1 LRRCT domain and 1 LRRNT domain. LRIG1 / LIG-1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. LRIG1 / LIG-1 is an endogenous inhibitor of growth factor signaling and a proposed tumor suppressor. LRIG1 / LIG-1 may be overexpressed in prostate cancer. LRIG1 / LIG-1 is an important determinant of prostate cancer growth, and the implications of its expression on patient outcome depend on the clinical and biological circumstances. LRIG1 / LIG-1 evolved in gliomas as a rare feedback negative attenuator of EGFR and could offer a novel therapeutic target to treat patients with malignant gliomas.
參考文獻
Hedman,H. et al., 2002, Acta Oncol. 41 (4):352-4.
Nilsson,J. et al., 2003, Cell Tissue Res. 312 (1):65-71.
Ye,F. et al., 2009, J Neurooncol. 94 (2):183-94.
Thomasson,M. et al., 2011, Int J Cancer. 128 (12):2843-52.

包裝：20ug

1、產品質量問題，在產品售出7日內提出異議并且產品未有損壞，試劑類產品，需要提供詳細的檢測數據，創賽負責免費退換貨服務；
2、本產品屬于消耗品，不提供質保服務；
3、所有產品售后問題，請直接聯系我司，我們將會盡快為您響應處理
查詢關鍵詞：重組小鼠 LRIG1 / LIG-1 蛋白，Mouse LRIG1 / LIG-1 Protein，技術資料，產品詳情，原料藥，大包裝定制，現貨促銷，醫藥中間體，科學儀器，實驗室耗材，生化試劑，創賽中國,細胞因子
CANSPEC品質提供的重組小鼠 LRIG1 / LIG-1 蛋白|Mouse LRIG1 / LIG-1 Protein|技術資料|產品詳情性能**，其優良的品質滿足您不同實驗的多種需求。
本產品由上海創賽品質提供，歡迎咨詢國內免費服務專線：400-608-7598，更多產品信息請登錄m.aysxmc.cn或www.4006087598.com